Neuropilin‐1 (NRP1) is an immune checkpoint that inhibits Tpex cell self‐renewal, and mice with NRP1‐deficient CD8+ T cells were protected against tumour rechallenge and showed an enhanced response to anti‐PD1 immunotherapy.38 The gene discussed is CD8A; the disease is neoplasm.